Cocrystal Pharma Files 8-K
Ticker: COCP · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1412486
| Field | Detail |
|---|---|
| Company | Cocrystal Pharma, INC. (COCP) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, disclosure, financials
TL;DR
Cocrystal Pharma filed an 8-K on 7/10/25 - check for Reg FD and financial updates.
AI Summary
Cocrystal Pharma, Inc. filed an 8-K on July 10, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, incorporated in Delaware, is based in Bothell, WA, with a principal executive office at 19805 N. Creek Parkway. The filing does not contain specific financial figures or details about the nature of the disclosure or exhibits.
Why It Matters
This 8-K filing indicates that Cocrystal Pharma, Inc. has made a regulatory disclosure and submitted financial statements and exhibits to the SEC, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, with no immediate indication of significant negative events.
Key Players & Entities
- Cocrystal Pharma, Inc. (company) — Registrant
- July 10, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Bothell, WA (location) — Principal executive offices location
- 19805 N. Creek Parkway (address) — Principal executive offices address
- 001-38418 (identifier) — Commission File Number
- 35-2528215 (identifier) — IRS Employer Identification No.
- (877) 262-7123 (phone_number) — Registrant's telephone number
FAQ
What specific information is being disclosed under Regulation FD?
The filing does not specify the details of the Regulation FD disclosure.
What are the key financial statements or exhibits being filed?
The filing indicates that financial statements and exhibits are being filed, but their specific content is not detailed in the provided text.
Has Cocrystal Pharma, Inc. undergone any recent name changes?
The filing mentions former company names, BIOZONE PHARMACEUTICALS, INC. (name change date: 20110304) and International Surf Resorts, Inc. (name change date: 20070917), but no recent changes are indicated for the current report date.
What is the primary business of Cocrystal Pharma, Inc. according to the filing?
The filing lists the Standard Industrial Classification as 'PHARMACEUTICAL PREPARATIONS [2834]'.
Where is Cocrystal Pharma, Inc. headquartered?
The company's principal executive offices are located at 19805 N. Creek Parkway, Bothell, WA 98011.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding Cocrystal Pharma, Inc. (COCP).